3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Other
1
Conditions
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Leukemia
11
Lymphoma
8
Leukemia, Lymphocytic, Chronic, B-Cell
4
Waldenstrom Macroglobulinemia
3
Sezary Syndrome
3
Mycosis Fungoides
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Recurrence
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Leukemia, Large Granular Lymphocytic
2
Leukemia, Biphenotypic, Acute
2
Immunoblastic Lymphadenopathy
2
Burkitt Lymphoma
2
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mucositis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Interventions
angiotensin I (1-7)
4
pegaspargase
1
nelarabine
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Vincristine
1
Rituximab
1
Radiotherapy
1
Quercetin
1
Passive Cutaneous Anaphylaxis
1
Morphine
1
Methotrexate
1
Methadone
1
Mercaptopurine
1
Melphalan
1
Laser Therapy
1
Imatinib Mesylate
1
Hydromorphone
1
Gelclair
1
Fibroblast Growth Factor 7
1
Etoposide
1
Drug Therapy
1
Daunorubicin
1
Cytarabine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mucositis
×
nelarabine
×
Other hematologic neoplasm
×
Clear all
NCT01085617
2025-03-30
UKALL14
University College, London
Completed